Table II.

Clinical criteria of high bleeding and ischemic risks

Bleeding risk

Ischemic risk

• Female gender • Iron deficiency anemia • Stroke (hemorrhagic or ischemic) history • Diabetes mellitus treated with medications (oral hypoglycemic therapy or subcutaneous insulin) • Chronic kidney disease defined as an estimated glomerular filtration rate< 60 mL/min per 1.73 m2 or creatinine clearance <60 mL/min

• Multivessel coronary artery disease • Target lesion requiring total stent length >30 mm • Thrombotic target lesion • Bifurcation lesions with Medina 0, 1, 1 or 1, 1, 1 classification requiring at least 2 stents • Left main (≥50%) or proximal LAD (≥70%) lesion • Calcified target lesion(s) requiring atherectomy • Troponin-positive ACS • Established vascular disease defined as previous MI, ischemic stroke, diagnosed PAD, or CAD/PAD revascularization • Repeat MI, coronary revascularization, stent thrombosis, stroke within prior 9 m before index PCI • Diabetes mellitus treated with medications (oral hypoglycemic therapy or subcutaneous insulin) • Chronic kidney disease defined as an estimated glomerular filtration rate <60 mL/min per 1.73 m2 or creatinine clearance <60 mL/min

LAD, left anterior descending; PAD, peripheral artery disease; CAD, coronary artery disease; MI, myocardial infarction.